Cargando…

Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold

Dependency on mitochondrial oxidative phosphorylation (OxPhos) is a potential weakness for leukemic stem cells (LSC) that can be exploited for therapeutic purposes. Fatty acid oxidation (FAO) is a crucial OxPhos-fueling catabolic pathway for some acute myeloid leukemia (AML) cells, particularly chem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griessinger, Emmanuel, Pereira-Martins, Diego, Nebout, Marielle, Bosc, Claudie, Saland, Estelle, Boet, Emiline, Sahal, Ambrine, Chiche, Johanna, Debayle, Delphine, Fleuriot, Lucile, Pruis, Maurien, De Mas, Véronique, Vergez, François, Récher, Christian, Huls, Gerwin, Sarry, Jean-Emmanuel, Schuringa, Jan Jacob, Peyron, Jean-François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Priority Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391327/ https://www.ncbi.nlm.nih.gov/pubmed/37272750 http://dx.doi.org/10.1158/0008-5472.CAN-23-1006

Ejemplares similares

Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
por: Larrue, Clément, et al.
Publicado: (2021)

Dexamethasone in hyperleukocytic acute myeloid leukemia
por: Bertoli, Sarah, et al.
Publicado: (2018)

CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
por: Farge, Thomas, et al.
Publicado: (2023)

Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites
por: Bosc, Claudie, et al.
Publicado: (2020)

Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia
por: Larrue, Clément, et al.
Publicado: (2019)

Hypoxia-Like Signatures Induced by BCR-ABL Potentially Alter the Glutamine Uptake for Maintaining Oxidative Phosphorylation
por: Sontakke, Pallavi, et al.
Publicado: (2016)

A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia
por: Saland, E, et al.
Publicado: (2015)

Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo
por: Serhan, Nizar, et al.
Publicado: (2020)

Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability
por: Erdem, Ayşegül, et al.
Publicado: (2022)

Activation of Vitamin D Receptor Pathway Enhances Differentiating Capacity in Acute Myeloid Leukemia with Isocitrate Dehydrogenase Mutations
por: Sabatier, Marie, et al.
Publicado: (2021)

SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-Kinase
por: Ounoughene, Youcef, et al.
Publicado: (2021)

Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia
por: Vergez, François, et al.
Publicado: (2022)

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia
por: Bertoli, Sarah, et al.
Publicado: (2015)

Disrupting Mitochondrial Electron Transfer Chain Complex I Decreases Immune Checkpoints in Murine and Human Acute Myeloid Leukemic Cells
por: Luna-Yolba, Raquel, et al.
Publicado: (2021)

Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia
por: Mouchel, Pierre-Luc, et al.
Publicado: (2020)

Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2(V617F) myeloproliferative neoplasms
por: Courdy, Charly, et al.
Publicado: (2023)

The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia
por: Erdem, Ayşegül, et al.
Publicado: (2022)

New Drug Repositioning Candidates for T-ALL Identified Via Human/Murine Gene Signature Comparison
por: Bonnet, Raphaël, et al.
Publicado: (2020)

RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia
por: Decroocq, Justine, et al.
Publicado: (2022)

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience
por: LaRochelle, Olivier, et al.
Publicado: (2011)

P1345: EFFECT OF DECITABINE ON MACROPHAGE PHENOTYPE AND FUNCTION IN VITRO IN THE CONTEXT OF AML
por: Hilberink, Jacobien, et al.
Publicado: (2023)

Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia
por: Cerella, C, et al.
Publicado: (2017)

Structure–function insights reveal the human ribosome as a cancer target for antibiotics
por: Myasnikov, Alexander G., et al.
Publicado: (2016)

Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
por: Boutzen, Héléna, et al.
Publicado: (2016)

Vitamin C and D supplementation in acute myeloid leukemia
por: Mouchel, Pierre Luc, et al.
Publicado: (2023)

From Immune Dysregulations to Therapeutic Perspectives in Myelodysplastic Syndromes: A Review
por: Comont, Thibault, et al.
Publicado: (2021)

Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia
por: Muselli, Fabien, et al.
Publicado: (2023)

Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022)

CD34(+)CD38(−)CD123(+) Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents
por: Vergez, François, et al.
Publicado: (2020)

The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis
por: de Boer, Bauke, et al.
Publicado: (2020)

Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies
por: Bertoli, Sarah, et al.
Publicado: (2016)

Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia
por: Stuani, Lucille, et al.
Publicado: (2021)

HIF1/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem/progenitor cells
por: Wierenga, Albertus T. J., et al.
Publicado: (2019)

Modification of Salmonella Typhimurium Motility by the Probiotic Yeast Strain Saccharomyces boulardii
por: Pontier-Bres, Rodolphe, et al.
Publicado: (2012)

The Saccharomyces boulardii CNCM I-745 Strain Shows Protective Effects against the B. anthracis LT Toxin
por: Pontier-Bres, Rodolphe, et al.
Publicado: (2015)

Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes
por: Galtier, Jean, et al.
Publicado: (2021)

Dendrogenin A drives LXR to trigger lethal autophagy in cancers
por: Segala, Gregory, et al.
Publicado: (2017)

Metformin, an Anti-diabetic Drug to Target Leukemia
por: Biondani, Giulia, et al.
Publicado: (2018)

NF-κB in Hematological Malignancies
por: Imbert, Véronique, et al.
Publicado: (2017)

Skeletal muscle sarcomeric SHG patterns photo-conversion by femtosecond infrared laser
por: Recher, Gaëlle, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nm69t6v35p3reivdk364no9cfn